Aarti Drugs

The Company  was formed in 1984 and has established a strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.
The manufacturing-units of ADL are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved. The Company aims at becoming the first choice of this expanding market through better products, ensuring quality and timely delivery.



The company is able to deliver constant good results throughout. The QoQ and YoY results have been beating the previous numbers and creating new highs every time. The profits have increased by 35% over the year due to increase in their operating and net profit margins. With huge acquisition of the stock by promoters in recent times, it seems the next quarter results are going to be outstanding. The company has given hefty amount of dividends at regular intervals which indicates the quality of the management. The liquidity ratios are stable but the only concern is the high debt of the company which will be resolved by company as they are making strategies to reduce it. The P/E ratio is 12 and there is a lot of potential left if we compare it to company's P/E and the EPS is also very high. With CMP, it is looking good for a buy and one can enter at dips.